Semaglutide: First global approval
However, like other drugs in its class, tirzepatide shares a similar safety profile, with specific side effects that patients should be aware of
Glucagon was traditionally considered counterproductive for weight management because it raises blood sugar
Incretin-based drugs are now being investigated and in some cases approved for a wide range of conditions, including cardiovascular disease, neurodegenerative disorders, and even substance use disorder
What are GLP-1 medications and how do they work Medically reviewed by Dr Sultan Linjawi, Endocrinologist & Diabetes Specialist January 2026 GLP-1 medications have become some of the most talked-about treatments in type 2 diabetes and for good reason
Understanding this pattern helps you plan your titration strategically and avoid unnecessary protocol interruptions